4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-24-001597
Director sold 29,350 shares at an average $87.49 ($2,567,754)
- Director acquired 29,350 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
MUSSALLEM MICHAEL A · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-05 | Exercise or conversion : show line 1 in the form 10b5-1 | +29,350 | $36.75 | $1,078,613 | 33,835.82 | D |
| 2024-02-05 | Sale : show line 2 in the form 10b5-1 | −1,000 | $89.61 | $89,610 | 32,835.82 | D |
| 2024-02-05 | Sale : show line 3 in the form 10b5-1 | −6,422 | $88.63 | $569,182 | 26,413.82 | D |
| 2024-02-05 | Sale : show line 4 in the form 10b5-1 | −9,761 | $86.44 | $843,741 | 16,652.82 | D |
| 2024-02-05 | Sale : show line 5 in the form 10b5-1 | −12,167 | $87.55 | $1,065,221 | 4,485.82 | D |
| Open-market sales · 29,350 sh · avg $87.49 · $2,567,754 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2024-02-05 | Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −29,350 | $36.75 | 2024-05-10 | 29,350 | 88,050 | D |
Loading xslF345X05/doc4.xml…